Cite
HARVARD Citation
Lee, J. et al. (2016). Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study. Cancer imaging. 16 (1), pp. 1-8. [Online].